Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Recruiting · NCT06702293 · Interventional (participants receive a specific treatment) · Lead sponsor: National University Hospital, Singapore
View the official record on ClinicalTrials.gov →Interventions studied
Digital psychotherapeutic interventionHealthy365
What this trial is about
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.
Who can take part
Age range
16 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with psoriasis, eczema or chronic urticaria diagnosed by a dermatologist
- Aged 16 or older
- Peak pruritus intensity of 4 or more on a 11-point numerical rating scale (0-10, with 10 representing worst itch)
- Able to engage with a mobile application in the English language
Exclusion criteria
- Patients with active psychiatric symptoms (e.g. active suicidal ideation, psychosis, delusions)
- Patients with unstable psychiatric condition, characterized by
- Hospital inpatient admission for a psychiatric condition or initiation of a psychotropic medication in the prior 3 months
- Patients with unstable dermatological condition, characterized by
- Recent flare of the skin condition within the last 2 weeks, including diagnosis of a flare by a doctor, use of systemic steroids, oral antibiotics, wet wrap rescue therapy, oral antivirals, or increase in frequency of phototherapy or dose of systemic medications for the dermatological condition within the last 2 weeks OR
- Any of the following within 3 months
- inpatient admission for a dermatological condition
- Initiation of phototherapy
- Initiation of systemic therapy (conventional immunosuppressive agent, biologics, JAK inhibitors) within the last 3 months.
Where it is running
2 locations listed.
- National University Hospital - Singapore, Singapore, Singapore
- National University Hospital - Singapore, Singapore, Singapore